Eastern Europe & Baltic Course I: Immunotherapy in Lung Cancer

IASLC Best Practices and Research Advances in Thoracic Oncology a Regional Series - EE

Description

Join us for this exclusive course on the latest updates on lung cancer treatment in Eastern Europe & the Balkan States, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Join us to explore how immunotherapy is transforming the landscape of lung cancer treatment in Eastern Europe & the Balkan States, bringing hope for improved patient outcomes.

 

Image
REGIONAL SERIES EE-BALKANS 1

Learning Objectives

Discuss the role of immunotherapy across all stages of lung cancer.

Date and Time
Dec 30, 2024 10:00 am -
Location

Zoom

CME Accredited